Predictor variables | TB treatment outcomes | COR (95 % CI), P-value | AOR (95Â % CI), P-value | |
---|---|---|---|---|
Unsuccessful N (%) | Success full N (%) | |||
Sex | ||||
 Female | 63 (24.4) | 195 (75.6) | 0.58 (0.4–0.87), 0.007 | 0.26 (0.06–1.13),0.26 |
 Male | 66 (16.0) | 347 (84.0) | 1 | 1 |
Age | ||||
 <=14 | 6 (12.5) | 42 (87.5) | 2.57 (0.76–8.71),0.13 | 2.4 (0.63–9.12),0.20 |
 15–24 | 24 (8.3) | 266 (91.7) | 4.08 (1.56–10.68), 0.04 | 2.91 (1.00–8.45),0.04 |
 25–34 | 47 (27.2) | 126 (72.8) | 0.98 (0.39–2.50), 0.98 | 1.22 (0.43–3.46),0.70 |
 35–44 | 30 (31.9) | 64 (68.1) | 0.78 (0.29–2.07),0.62 | 1.10 (0.37–3.29),0.86 |
 45–54 | 15 (37.5) | 25 (62.5) | 0.61 (0.20–1.80), 0.37 | 1.34 (0.39–4.84),0.61 |
 ≥55 | 7 (26.9) | 19 (73.1) | 1 | 1 |
Residence | ||||
 Rural | 42 (72.4) | 16 (27.6) | 15.87 (8.55–29.47), 0.00 | 18.0 (9.06–37.82),0.001 |
 Urban | 87 (14.2) | 526 (85.8) | 1 | 1 |
Types of TB | ||||
 PTB+ | 17 (14.2) | 103 (85.8) | 1.83 (1.03–3.24),0.03 | 1.90 (0.92–3.90),0.08 |
 PTB- | 36 (16.1) | 187 (83.9) | 1.57 (1.01–2.43),0.04 | 1.46 (0.86–2.46),0.154 |
 EPTB | 76 (23.2) | 252 (76.8) | 1 | 1 |
HIV Status | ||||
 Positive | 70 (38.7) | 111 (61.3) | 4.6 (3.06–6.93),0.001 | 4.29 (2.20–8.37), 0.001 |
 Negative | 56 (12.0) | 412 (88.0) | 4.62 (1.33–16.02),0.016 | 3.70 (0.88–16.17),0.07 |
 Unknown | 3 (13.6) | 19 (86.4) | 1 | 1 |
History of TB | ||||
 New | 117 (21.9) | 418 (78.1) | 1 | 1 |
 Retreated | 7 (36.8) | 12 (63.2) | 6.27 (2.50–15.71),0.001 | 5.32 (1.92–14.3),0.001 |
 Transfer in | 5 (4.5) | 107 (95.5) | 10.48 (0.18–1.24),0.13 | 0.23 (0.08–0.70),0.01 |
 Other | 0 (0) | 5 (100) |  |  |
CPT Took | ||||
 Yes | 42 (34.4) | 80 (65.6) | 2.79 (1.80–4.32),0.001 | 1.32 (0.65–2.61),0.45 |
 No | 87 (15.8) | 462 (84.2) | 1 | 1 |